Key result
An extended period of antimicrobial therapy successfully treated a 52-year-old female with native tricuspid valve endocarditis due to E. coli, suggesting surgery may not be mandatory.
Case Report (n=1)
Extended antimicrobial therapy may be sufficient for treating E. coli native tricuspid valve endocarditis without the need for surgery.
Answers are grounded in this paper and cite their sources.
Prolonged antibiotics may suffice for E. coli native tricuspid endocarditis; hypothesis-generating and should not yet change practice.
Despite being the most common gram-negative organism associated with bacteremia, Escherichia coli remains an uncommon cause of infective endocarditis. Herein, a 52-year-old female without preexisting valvular heart disease representing with E. coli urosepsis associated with unexplained heart murmur and anemia, and therefore being proven of tricuspid valve endocarditis by transesophageal echocardiography, was reported. She survived after extended period of antimicrobial therapy. Surgery is probably no longer to be mandatory in treating this serious infection.
No takes yet. Share an insight, caveat, or question.
Ching-Huei Yang (2010) conducted a case report in Native Tricuspid Valve Endocarditis Due to Escherichia coli (n=1). Antimicrobial therapy was evaluated on Survival. An extended period of antimicrobial therapy successfully treated a 52-year-old female with native tricuspid valve endocarditis due to E. coli, suggesting surgery may not be mandatory.
Synapse has enriched 10 related papers. Consider them for comparative context: